<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE topic
  PUBLIC "-//IFRS//DTD DITA Topic//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/ifrsTopic.dtd">
<topic id="IFRS17_TOC"><title/><body><ol reference_label="paragraph" toc_label="contents" type="toc"><li outputclass="primary"><ph outputclass="standard_ref"><ph outputclass="standard_number">IFRS 17</ph> <ph outputclass="standard_title">INSURANCE CONTRACTS</ph></ph></li><li><xref base="F58984111" href="IFRS17_g1-2.dita#IFRS17_g1-2/IFRS17_g1-2_TI" id="IFRS17_X0001">OBJECTIVE</xref><entry_ref>1</entry_ref></li><li><xref base="F58984229" href="IFRS17_g3-13.dita#IFRS17_g3-13/IFRS17_g3-13_TI" id="IFRS17_X0002">SCOPE</xref><entry_ref>3</entry_ref>         <ol type="toc"><li><xref base="F59117316" href="IFRS17_g9-9.dita#IFRS17_g9-9/IFRS17_g9-9_TI" id="IFRS17_X0003">Combination of insurance contracts</xref><entry_ref>9</entry_ref></li><li><xref base="F59117317" href="IFRS17_g10-13.dita#IFRS17_g10-13/IFRS17_g10-13_TI" id="IFRS17_X0004">Separating components from an insurance contract</xref><entry_ref>10</entry_ref></li></ol>       </li><li><xref base="F59117318" href="IFRS17_g14-24.dita#IFRS17_g14-24/IFRS17_g14-24_TI" id="IFRS17_X0005">LEVEL OF AGGREGATION OF INSURANCE CONTRACTS</xref><entry_ref>14</entry_ref></li><li><xref base="F59117319" href="IFRS17_g25-28.dita#IFRS17_g25-28/IFRS17_g25-28_TI" id="IFRS17_X0006">RECOGNITION</xref><entry_ref>25</entry_ref>         <ol type="toc" base="IFRS2020-3"><li><xref href="IFRS17_g28A-28F.dita#IFRS17_g28A-28F/IFRS17_g28A-28F_TI">Insurance acquisition cash flows</xref><entry_ref>28A</entry_ref></li></ol></li><li><xref base="F59117320" href="IFRS17_g29-71.dita#IFRS17_g29-71/IFRS17_g29-71_TI" id="IFRS17_X0007">MEASUREMENT</xref><entry_ref>29</entry_ref>         <ol type="toc"><li><xref base="F59117321" href="IFRS17_g32-39.dita#IFRS17_g32-39/IFRS17_g32-39_TI" id="IFRS17_X0008">Measurement on initial recognition</xref><entry_ref>32</entry_ref></li><li><xref base="F59117322" href="IFRS17_g40-46.dita#IFRS17_g40-46/IFRS17_g40-46_TI" id="IFRS17_X0009">Subsequent measurement</xref><entry_ref>40</entry_ref></li><li><xref base="F59117323" href="IFRS17_g47-52.dita#IFRS17_g47-52/IFRS17_g47-52_TI" id="IFRS17_X0010">Onerous contracts</xref><entry_ref>47</entry_ref></li><li><xref base="F59117324" href="IFRS17_g53-59.dita#IFRS17_g53-59/IFRS17_g53-59_TI" id="IFRS17_X0011">Premium allocation approach</xref><entry_ref>53</entry_ref></li><li><xref base="F59117325" href="IFRS17_g60-70.dita#IFRS17_g60-70/IFRS17_g60-70_TI" id="IFRS17_X0012">Reinsurance contracts held</xref><entry_ref>60</entry_ref></li><li><xref base="F59117402" href="IFRS17_g71-71.dita#IFRS17_g71-71/IFRS17_g71-71_TI" id="IFRS17_X0013">Investment contracts with discretionary participation features</xref><entry_ref>71</entry_ref></li></ol>       </li><li><xref base="F59117403" href="IFRS17_g72-77.dita#IFRS17_g72-77/IFRS17_g72-77_TI" id="IFRS17_X0014">MODIFICATION AND DERECOGNITION</xref><entry_ref>72</entry_ref>         <ol type="toc"><li><xref base="F59117404" href="IFRS17_g72-73.dita#IFRS17_g72-73/IFRS17_g72-73_TI" id="IFRS17_X0015">Modification of an insurance contract</xref><entry_ref>72</entry_ref></li><li><xref base="F59117405" href="IFRS17_g74-77.dita#IFRS17_g74-77/IFRS17_g74-77_TI" id="IFRS17_X0016">Derecognition</xref><entry_ref>74</entry_ref></li></ol>       </li><li><xref base="F59117406" href="IFRS17_g78-79.dita#IFRS17_g78-79/IFRS17_g78-79_TI" id="IFRS17_X0017">PRESENTATION IN THE STATEMENT OF FINANCIAL POSITION</xref><entry_ref>78</entry_ref></li><li><xref base="F59117407" href="IFRS17_g80-92.dita#IFRS17_g80-92/IFRS17_g80-92_TI" id="IFRS17_X0018">RECOGNITION AND PRESENTATION IN THE STATEMENT(S) OF FINANCIAL PERFORMANCE</xref><entry_ref>80</entry_ref>         <ol type="toc"><li><xref base="F59117408" href="IFRS17_g83-86.dita#IFRS17_g83-86/IFRS17_g83-86_TI" id="IFRS17_X0019">Insurance service result</xref><entry_ref>83</entry_ref></li><li><xref base="F59117409" href="IFRS17_g87-92.dita#IFRS17_g87-92/IFRS17_g87-92_TI" id="IFRS17_X0020">Insurance finance income or expenses</xref><entry_ref>87</entry_ref></li></ol>       </li><li><xref base="F59117410" href="IFRS17_g93-132.dita#IFRS17_g93-132/IFRS17_g93-132_TI" id="IFRS17_X0021">DISCLOSURE</xref><entry_ref>93</entry_ref>         <ol type="toc"><li><xref base="F59117411" href="IFRS17_g97-116.dita#IFRS17_g97-116/IFRS17_g97-116_TI" id="IFRS17_X0022">Explanation of recognised amounts</xref><entry_ref>97</entry_ref></li><li><xref base="F59117543" href="IFRS17_g117-120.dita#IFRS17_g117-120/IFRS17_g117-120_TI" id="IFRS17_X0023">Significant judgements in applying IFRS 17</xref><entry_ref>117</entry_ref></li><li><xref base="F59117544" href="IFRS17_g121-132.dita#IFRS17_g121-132/IFRS17_g121-132_TI" id="IFRS17_X0024">Nature and extent of risks that arise from contracts within the scope of IFRS 17</xref><entry_ref>121</entry_ref></li></ol>       </li><li><xref base="F59117545" href="IFRS17_APPA.dita#IFRS17_APPA/IFRS17_APPA_TI">APPENDICES</xref>         <ol type="toc"><li><xref base="F59117545" href="IFRS17_APPA.dita#IFRS17_APPA/IFRS17_APPA_TI" id="IFRS17_X0025">A Defined terms</xref></li><li><xref base="F59117546" href="IFRS17_APPB.dita#IFRS17_APPB/IFRS17_APPB_TI" id="IFRS17_X0026">B Application guidance</xref></li><li><xref base="F59117547" href="IFRS17_APPC.dita#IFRS17_APPC/IFRS17_APPC_TI" id="IFRS17_X0027">C Effective date and transition</xref></li><li audience="markup"><xref base="F59117548" href="IFRS17_APPD.dita#IFRS17_APPD/IFRS17_APPD_TI" id="IFRS17_X0028">D Amendments to other IFRS Standards</xref></li></ol>       </li><li audience="markup"><xref base="F59117549" href="IFRS17_BAMay2017.dita#IFRS17_BAMay2017/IFRS17_BAMay2017_TI" id="IFRS17_X0029">APPROVAL BY THE BOARD OF <ph outputclass="standard_ref"><ph outputclass="standard_number">IFRS 17</ph> <ph outputclass="standard_title">INSURANCE CONTRACTS</ph></ph></xref></li><li base="IFRS2020-3"><xref href="IFRS17_BAJun2020.dita#IFRS17_BAJun2020/IFRS17_BAJun2020_TI">APPROVAL BY THE BOARD OF <ph outputclass="standard_ref"><ph outputclass="standard_title">AMENDMENTS TO IFRS 17</ph></ph> ISSUED IN JUNE 2020</xref></li><li base="IFRS2021-2"><xref href="IFRS17_BADec2021.dita#IFRS17_BADec2021/IFRS17_BADec2021_TI">APPROVAL BY THE BOARD OF <ph outputclass="standard_ref"><ph outputclass="standard_title">INITIAL APPLICATION OF IFRS 17 AND IFRS 9&#x2014;COMPARATIVE INFORMATION</ph></ph> ISSUED IN DECEMBER 2021</xref></li><li audience="markup">         <note othertype="box" type="other">FOR THE ACCOMPANYING GUIDANCE LISTED BELOW, SEE PART B OF THIS EDITION</note>       </li><li audience="markup"><xref base="F59117551" href="IFRS17_IE_TOC.dita#IFRS17_TOC0003" id="IFRS17_X0030">ILLUSTRATIVE EXAMPLES</xref> </li><li audience="markup">                </li><li audience="markup">         <note othertype="box" type="other">FOR THE BASIS FOR CONCLUSIONS, SEE PART C OF THIS EDITION</note>       </li><li audience="markup"><xref base="F59117550" href="IFRS17_BC_TOC.dita#IFRS17_TOC0005" id="IFRS17_X0032">BASIS FOR CONCLUSIONS</xref> </li></ol></body></topic>